The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global preclinical assets market is projected to rise from $4.84 billion in 2022 to $5.32 billion in 2023 with a 9.9% CAGR, and is anticipated to reach $7.62 billion in 2027 at a 9.4% CAGR.

North America held the largest preclinical assets market share, and Asia-Pacific was the fastest-growing region in 2022.

Preclinical Assets Market Driver
Rising drug discovery drives the preclinical asset market. Drug discovery, the quest for medicinal compounds, plays a vital role in selecting clinical development candidates, supported by preclinical assets. In January 2022, 74% of FDA-approved drugs used expedited pathways, up from 68% in 2020, as reported by the Regulatory Affairs Professionals Society. In June 2023, Pharma Intelligence noted that the R&D drug pipeline increased from 17,737 to 20,109, strengthening the preclinical asset market’s growth linked to increasing drug discovery.

View More On The Preclinical Assets Market Report 2023 – https://www.thebusinessresearchcompany.com/report/preclinical-assets-global-market-report

Prominent Preclinical Assets Market Trend
Innovating products is a prominent trend in the preclinical assets market. Major companies in this sector prioritize product and solution innovation to enhance their market position and gain a competitive edge. For example, in April 2022, Charles River Laboratories International and Valo Health Inc. jointly introduced Logica, an AI-powered drug solution that translates biological insights into optimized preclinical assets, integrating Charles River’s expertise with Valo’s Opal Computational Platform to streamline drug discovery. This strategic partnership enhances lead and candidate quality while aligning costs with value creation, revolutionizing the industry.

Preclinical Assets Market Prominent Players
Major players in the preclinical assets market are Laboratory Corporation of America, IQVIA Inc., ICON PLC, Eurofins Scientific SE, PPD Inc., SGS SA, WuXi AppTec Co. Ltd., Intertrek Group PLC, Charles River Laboratories International Inc., Medpace Inc., Pharmaron Beijing Co. Ltd., Evotec SE, GenScript Biotech Corporation, Inotiv Inc., SRI International Inc., Shanghai Medicilon Inc., Biocytogen Pharmaceuticals Beijing Co. Ltd., AmplifyBio LLC, BioReliance Corporation, Pharmalegacy Laboratories Co. Ltd., Precigen Inc., ReproCELL Incorporated, InSphero AG, Crown Bioscience Inc., Comparative Biosciences Inc., TCG Lifesciences Pvt. Ltd., InVivo Biosystems, Pharmatest Services Ltd, Domainex Limited, and Viroclinics Xplore.

Request A Sample Of The Global Preclinical Assets Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12600&type=smp

Key Preclinical Assets Market Segments
The global preclinical assets market is segmented –
1) By Service: Bioanalysis And DMPK (Drug Metabolism and Pharmacokinetic) studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services
2) By Model Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By End User: Biopharmaceutical Companies, Government Institutes, Other End-Users

The Preclinical Assets Global Market Report 2023  provides a comprehensive overview on the preclinical assets market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the preclinical assets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Preclinical Imaging Global Market Report 2023
Preclinical CRO Global Market Report 2023
Asset Finance Software Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model